Venetoclax and azacitidine (VenAZA) combination therapy in young unfit patients with AML: a perspective from a developing country
Jayastu Senapati(The University of Texas MD Anderson Cancer Center), Tulika Seth(Manipal Academy of Higher Education), Rishi Dhawan(All India Institute of Medical Sciences), Pradeep Kumar(All India Institute of Medical Sciences), Seema Tyagi(All India Institute of Medical Sciences Raipur), Manoranjan Mahapatra(All India Institute of Medical Sciences), Mukul Aggarwal(All India Institute of Medical Sciences), Ganesh Kumar Vishwanathan(All India Institute of Medical Sciences), Jasmita Dass(Sir Ganga Ram Hospital)
Cited by 13
Related Papers
A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A
|New England Journal of Medicine|2016|494
Platelet activation determines the severity of thrombocytopenia in dengue infection
|Scientific Reports|2017|198
Autologous stem cell transplantation in refractory Asherman′s syndrome: A novel cell based therapy
|Journal of Human Reproductive Sciences|2014|184
Environmental and occupational determinants of lung cancer
|Translational Lung Cancer Research|2019|171
Recommendations for screening and early detection of common cancers in India
|The Lancet Oncology|2015|125